Table 3.
Unadjusted and Adjusted Prevalence Ratios for Being Prescribed Antiretroviral Therapy by Healthcare Payer Type Among Human Immunodeficiency Virus (HIV)-infected Adults Receiving Medical Care With Healthcare Coverage or Assistance: Medical Monitoring Project, 2009–2013 (n = 17 560)
| Unadjusted Prevalence Ratio | 95% CI | P Value | Adjusteda Prevalence Ratio | 95% CI | P Value | |||
|---|---|---|---|---|---|---|---|---|
| RWHAP only | 1.00 | 1.00 | ||||||
| Private | 0.94 | .92 | .96 | <.01 | 0.94 | .92 | .96 | <.01 |
| Medicaid | 0.94 | .92 | .96 | <.01 | 0.93 | .92 | .95 | <.01 |
| Medicare | 0.98 | .95 | 1.01 | .26 | 0.96 | .92 | .99 | <.01 |
| Medicaid +Medicare | 1.00 | .98 | 1.02 | .79 | 0.96 | .95 | .98 | <.01 |
| Private+RWHAP | 1.01 | .99 | 1.03 | .33 | 1.00 | .98 | 1.02 | .79 |
| Medicaid+RWHAP | 1.01 | .99 | 1.02 | .32 | 1.00 | .98 | 1.01 | .66 |
| Medicare+RWHAP | 1.02 | 1.00 | 1.04 | .02 | 0.99 | .96 | 1.01 | .25 |
| Medicaid+Medicare+RWHAP | 1.02 | 1.00 | 1.04 | .01 | 0.99 | .97 | 1.02 | .59 |
| Other payer type | 0.98 | .97 | 1.00 | .13 | 0.97 | .95 | .99 | <.01 |
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; RWHAP, Ryan White HIV/AIDS Program.
a
Results from logistic regression model adjusted for age, race, time since HIV diagnosis, HIV disease stage.